Transcriptomic study of hepatocarcinoma cells exposed to sorafenib. Homo sapiens

sorafenib is the treatment of reference for hepatocellular carcinoma (HCC). We applied sorafenib on the human HCC cell line Huh7 and the subclone shRb, carrying a stable knock-down of the expression of the RB1 gene, a key regulator of liver carcinogenesis. Our aim was to better understand the physiologic and metabolic consequences of the exposure of HCC cells to sorafenib. We used microarrays to detail the global programme of gene expression at an early time point (9h) after exposure to sorafenib Overall design: Whole-genome microarrays were used to study the transcriptome of Huh7 cells exposed to Sorafenib